Office of Infectious Diseases
BSC Member Profiles
Ruth L. Berkelman, MD
Rollins Professor, Director of the Center for Public Health Preparedness and Research, and Director of the Emory Preparedness and Emergency Response Research Center, Emory University, Atlanta, Georgia
Dr. Berkelman is Rollins Professor and the Director of the Center for Public Health Preparedness and Research at Emory University, and a globally recognized expert in public health, infectious diseases, and disease surveillance. She began her public health career as an Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention, and later served as Deputy Director of the National Center for Infectious Diseases and as a Senior Advisor to the Director, achieving the rank of Assistant Surgeon General in the U.S. Public Health Service. Among her national leadership roles, Dr. Berkelman has served as chair of the Public and Scientific Affairs Board of the American Society for Microbiology, and as a trustee at Princeton University. She is a member of the Institute of Medicine of the National Academies and was appointed in 2007 to the National Biodefense Science Board. Dr. Berkelman is chair of the BSC, OID.
Kristy K. Bradley, DVM, MPH
State Epidemiologist and State Public Health Veterinarian, Oklahoma State Department of Health, Oklahoma City
Dr. Bradley, State Epidemiologist and State Public Health Veterinarian at the Oklahoma State Department of Health, has extensive experience in the prevention and control of infectious diseases, with particular focus on diseases transmitted from animals to humans. In her current position, she has provided consultation to other health professionals and the public on infectious diseases and has helped lead the state’s bioterrorism preparedness and response programs. Dr. Bradley also serves as an adjunct assistant professor in the College of Veterinary Medicine at Oklahoma State University and in the College of Public Health at the University of Oklahoma Health Sciences Center. Dr. Bradley has earned diplomat status in the American College of Veterinary Preventive Medicine and serves in several professional associations, including the Infectious Disease Steering Committee of the Council of State and Territorial Epidemiologists.
Michael T. Brady, MD
Associate Medical Director, Nationwide Children’s Hospital, Columbus, Ohio
Dr. Brady, Associate Medical Director of Nationwide Children’s Hospital, is a highly regarded leader and expert in pediatric infectious diseases, with specific clinical interests in HIV, vaccines, and healthcare-associated infections (HAIs). He has served as principal investigator on numerous clinical trials for the treatment of HIV infection, management of its associated complications, and measures for identification and prevention of HAIs. He is board certified in Pediatrics and Pediatric Infectious Diseases. Dr. Brady has held hospital physician leadership positions for 30 years, with early appointments as Physician Director of Epidemiology and Physician Director of the HIV Program at Children’s Hospital. He was Chair of the Department of Pediatrics at The Ohio State University from 2005–2013. He has served on several international, national, and state committees, including as chair of the Committee on Infectious Diseases of the American Academy of Pediatrics and as Associate Editor of the 2015 Red Book® (report of the Committee on Infectious Diseases). Additionally, Dr. Brady has served on editorial boards and as a reviewer of several medical/scientific publications, including Clinical Infectious Diseases and the American Journal of Infection Control.
Harry L. Chen, MD
Acting Secretary, Vermont Agency of Human Services, Williston
Dr. Chen, Acting Secretary of the Vermont Agency of Human Services, is nationally recognized for his public health expertise and perspective on healthcare transformation and electronic health records. He previously served as Commissioner of the Vermont Department of Health. Dr. Chen has extensive legislative experience, including as a three-term state representative in Vermont, serving his final term as Vice Chair of the House Committee on Health Care. In addition, Dr. Chen has more than 20 years’ experience as an emergency physician at Rutland (Vermont) Regional Medical Center, where he was Medical Director for approximately 6 years, and is on the clinical faculty at the University of Vermont College of Medicine. Additional expertise includes serving as vice chair of the Vermont Board of Medical Practice, as interim executive director of the Vermont Program for Quality in Health Care, and as a member of the Electronic Health Record Selection Workgroup, Vermont Information Technology Leaders.
Franklin R. Cockerill, III, MD
Chair, Department of Laboratory Medicine and Pathology, Mayo Clinic, and President and CEO, Mayo Medical Laboratories, Rochester, Minnesota
Dr. Cockerill is Chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and serves as Chief Executive Officer of Mayo Medical Laboratories, a global reference laboratory operating within Mayo Clinic. He is also the Ann and Leo Markin Professor of Microbiology and Medicine at the Mayo Clinic College of Medicine, with extensive experience and expertise in infectious diseases and antimicrobial resistance. Dr. Cockerill is board certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine and in Medical Microbiology by the American Board of Pathology. In addition to his Mayo administrative assignments, Dr. Cockerill currently holds several high-profile extramural leadership positions, including chair of the Subcommittee on Antimicrobial Susceptibility Testing, Clinical and Laboratory Standards Institute (CLSI); council member and chair-elect of the Program Committee of the Association for Molecular Pathology (AMP); and director, Board of Directors of the American Clinical Laboratory Association (ACLA). He also recently served as chair, Microbiology Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug Administration (FDA), and editor, Journal of Clinical Microbiology.
Timothy F. Jones, MD
State Epidemiologist, Communicable and Environmental Diseases and Emergency Preparedness, Tennessee Department of Health, Nashville
Dr. Jones is State Epidemiologist and directs the Communicable and Environmental Diseases and Emergency Preparedness section of the Tennessee Department of Health. He is responsible for many programs relevant to infectious disease prevention and control, including emerging infections, hospital infections, immunization, public health preparedness, strategic national stockpile, tuberculosis, disease surveillance, appropriate antibiotic use, and HIV/AIDS and sexually transmitted diseases. He also serves as clinical professor in the Department of Health Policy, Vanderbilt University School of Medicine. As a family physician, Dr. Jones has focused on providing medical care to underserved/impoverished patients. He is a widely recognized expert in foodborne disease epidemiology and serves as an international consultant on the topic for the World Health Organization and as chair of the Council to Improve Foodborne Outbreak Response. In addition, he is vice-president of the Council of State and Territorial Epidemiologists and a member of the editorial board of the journal Foodborne Pathogens and Disease.
Ruth Lynfield, MD
State Epidemiologist and Medical Director, Minnesota Department of Health, St. Paul
Dr. Lynfield, State Epidemiologist and Medical Director at the Minnesota Department of Health, is a highly regarded, nationally recognized public health leader and expert in infectious disease medicine and epidemiology. She leads Minnesota’s component of CDC’s Emerging Infections Program Active Bacterial Core Surveillance System, influenza projects, and healthcare-associated infections projects. She is also Adjunct Professor of medicine at the University of Minnesota. Previously, she attended in Pediatric Infectious Disease at Massachusetts General Hospital, and was Assistant Director of the New England Regional Newborn Screening Program, Massachusetts State Laboratory and Department of Health. Dr. Lynfield has served on many public health and infectious disease committees, including as a current member of the National Vaccine Advisory Committee, member of the Vaccines and Related Biological Products Advisory Committee of FDA, and co-chair of CDC’s Emerging Infections Program Steering Committee. In addition, she is a fellow of the Infectious Diseases Society of America (IDSA); is a member of the Pediatric Infectious Diseases Society; and has served as chair of IDSA’s National and Global Public Health Committee, and Antibiotic Resistance Working Group.
Laurene Mascola, MD, MPH, FAAP
Chief, Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, California
Dr. Mascola is Chief of the Acute Communicable Disease Control Program of the Los Angeles County Department of Public Health. She attended St. Louis University Medical School and earned her Master of Public Health degree from UCLA. She completed her pediatric residency at Children’s Hospital Los Angeles and completed residency and fellowship programs in preventive medicine. Dr. Mascola is a pediatrician and a member of the Alpha Omega Alpha Honor Medical Society. She served as an Epidemic Intelligence Service officer at CDC and was a field officer in Los Angeles County. She worked internationally for the World Health Organization in Ethiopia, and she has provided consultations in Brazil, Nepal, and Mongolia. Dr. Mascola has extensive experience in epidemiology and infectious disease prevention and control, publishing more than 100 articles and book chapters. She is a recipient of many honors and awards, including CDC/ATSDR Charles C. Shepard Science Awards, a Certificate of Appreciation from the U.S. Food and Drug Administration, and the American Academy of Pediatrics’ Outstanding Achievement in the Application of Epidemiologic Information to Child Health Advocacy Award in 2009, from the Section on Epidemiology and the Council on Community Pediatrics. In summer 2009, she was elected by the Council of State and Territorial Epidemiologists to be the chair of the Infectious Diseases Steering Committee, and became president-elect in 2011.
José Thier Montero, MD, MHCDS
Director, Division of Public Health Services, New Hampshire Department of Health and Human Services, Concord
Dr. Montero is Director of the Division of Public Health Services at the New Hampshire Department of Health and Human Services and has extensive experience in public health leadership and the prevention and control of infectious diseases. His major research interests include
vaccine-preventable diseases, epidemic response and preparedness, and the integration of public health and population approaches in clinical practice. In his current position, Dr. Montero leads the delivery of high-quality, evidence-based services and prompt response to public health threats and emerging issues in New Hampshire. Previous positions include Chief of the Bureau of Communicable Disease Control, State Epidemiologist, and Deputy Director for Public Health Emergency Preparedness and Response. Dr. Montero also holds national and regional committee leadership positions, including president of the Board of Directors of the Association of State and Territorial Health Officials (ASTHO) and chair of ASTHO’s Infectious Diseases Policy Committee. In addition, he holds adjunct assistant professorships in the School of Health and Human Services at the University of New Hampshire and in the Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth College.
Andrew Tobias Pavia, MD
George and Esther Gross Presidential Professor and Chief, Division of Pediatric Infectious Diseases, University of Utah, Salt Lake City
Dr. Pavia is George and Esther Gross Presidential Professor and Chief of the Division of Pediatric Infectious Diseases at the University of Utah and Hospital Epidemiologist at Primary Children’s Medical Center. He has extensive experience in the prevention and control of infectious diseases, with particular expertise in pediatrics, vaccines, and public health preparedness. His research interests include the epidemiology of influenza and other respiratory infections; vaccine-preventable diseases; diarrheal diseases; and HIV/AIDS, with special interest in the treatment of HIV in women and children and the prevention of mother-to-child transmission of HIV. Dr. Pavia has served on federal and state advisory committees on vaccine policy, biodefense, and pandemic influenza preparedness—including as a past chair of the Vaccine Safety Working Group of the National Vaccine Advisory Committee, current chair of the Pandemic Influenza Task Force of the Infectious Diseases Society of America (IDSA), and Board of Directors liaison to the National and Global Public Policy Committee of IDSA.
Scott C. Ratzan, MD, MPA
Editor-in-Chief, Journal of Health Communication: International Perspectives, and Vice President, Global Corporate Affairs, Anheuser-Busch InBev, New York, New York
Dr. Ratzan is Editor-in-Chief of the peer-reviewed Journal of Health Communication: International Perspectives, and Vice President, Global Corporate Affairs, Anheuser-Busch InBev. He has made major contributions to improve public health domestically and internationally, advancing public health policy through communication, health diplomacy, and innovative programs to improve lives. He is a pioneer in the areas of health literacy and mobile health (mHealth) communication, including the invention of the Digital Health Score, a single health literacy metric for noncommunicable disease prevention and care. Additionally, Dr. Ratzan serves as co-chair of the United Nations Secretary General’s Every Woman Every Child Innovation Working Group, is a member of the US Institute of Medicine (IOM) Roundtable on Health Literacy, serves on the World Economic Forum Global Agenda Council on
Lee W. Riley, MD
Professor and Chair, Division of Infectious Diseases and Vaccinology, University of California, Berkeley
Dr. Riley is Professor and Chair, Division of Infectious Diseases and Vaccinology at the University of California, Berkeley, and directs UC Berkeley’s Global Health Equity Scholars program of the Fogarty International Center. He is an internationally known expert in infectious diseases and public health. His research interests include molecular epidemiology of infectious diseases and bacterial pathogenesis, with particular emphasis on tuberculosis, enteric diseases, and drug-resistant gram-negative bacterial infections, as well as field epidemiology and international health, with a focus on urban informal settlements. He has decades of experience as a researcher in Asia, South America, and Mexico, including current tuberculosis research projects in Brazil. Additionally, he is an elected fellow of the American Association for the Advancement of Science, Infectious Diseases Society of America, and American Academy of Microbiology, and he serves on the editorial board of the journal Pathogens and Disease. Early in his career, Dr. Riley served as an Epidemic Intelligence Service Officer at CDC.
Susan Elaine Sharp, PhD
Medical Director of Airport Way Regional and Sunnyside Medical Center Laboratories and Regional Director of Microbiology, Department of Pathology, Kaiser Permanente Northwest, Portland, Oregon
Dr. Sharp is Medical Director of Airport Way Regional and Sunnyside Medical Center Laboratories as well as Regional Director of Microbiology for Kaiser Permanente Northwest. She is highly regarded nationally and internationally as a leader in clinical microbiology. At Kaiser Permanente, she oversees the daily operations of the microbiology laboratory and routinely consults with clinicians regarding interpretation of complex laboratory data. She also serves as an Affiliate Associate Professor in the Department of Pathology, School of Medicine, Oregon Health and Sciences University, and has presented numerous lectures, seminars, and workshops locally, nationally, and internationally. Dr. Sharp is a Diplomate of the American Board of Medical Microbiology (ABMM), chair of the American Society for Microbiology’s (ASM’s) Committee on Laboratory Practices, vice-chair of the ABMM, and a member of the editorial board of the Journal of Clinical Microbiology. In 2012, Dr. Sharp was the recipient of the prestigious Sonnenwirth Award for Leadership in Clinical Microbiology.
Jill Taylor, PhD
Director, Wadsworth Center, New York State Department of Health, Albany, New York
Dr. Taylor is Director of the Wadsworth Center, the state of New York’s public health reference laboratory and a premier institution for basic and directed research. She has extensive experience and expertise in public health and laboratory research, particularly related to the prevention and control of infectious diseases. Additionally, she serves as the Director-of-Record for the Wadsworth Center’s clinical laboratory. Prior to assuming the directorship, Dr. Taylor held various other leadership and research scientist positions at the Center and served as a senior research scientist at Virogenetics Corporation. At Wadsworth, Dr. Taylor has worked closely with national, state, and local organizations on infectious disease prevention and control. Among her professional activities, she has served and held leadership positions on committees of the Association of Public Health Laboratories.
Judith Nina Wasserheit, MD, MPH
Professor of Medicine and Global Health and Vice Chair, Department of Global Health, University of Washington, Seattle
Dr. Wasserheit is Professor of Medicine and Global Health and Vice Chair of the Department of Global Health at the University of Washington. She has extensive experience in sexually transmitted disease (STD) and HIV research, health policy development, and program implementation in the United States and developing countries. Her work addresses international health priorities and health disparities, and her research interests include the impact of HIV and other STDs on women and adolescents, STD/HIV interactions, HIV vaccine clinical trials, and the impact of climate change on human health. Previous positions include serving as Chief of the newly established Sexually Transmitted Diseases Branch at the National Institutes of Health (NIH), as Director of CDC’s STD prevention division, and as Director of the NIH-funded HIV Vaccine Trials Network. Dr. Wasserheit has served on numerous national and international committees, including her current membership on the NIH Office of AIDS Research Advisory Council. She is a member of the Institute of Medicine of the National Academies; is a Paul G. Rogers Society for Global Health Research Ambassador; and in 2009, was honored as the London School of Hygiene and Tropical Medicine’s Heath Clark Endowed Lecturer. In 2012, she assumed the chair of the Board of Directors of the Consortium of Universities for Global Health.
Robert A. Weinstein, MD
System Chair and Department Chair, Department of Medicine, Cook County Health and Hospitals System and John H. Stroger Jr. Hospital of Cook County, and Chief Operating Officer, Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases, Chicago, Illinois
Dr. Weinstein is System Chair and Department Chair of Medicine for the Cook County Health and Hospitals System and at John H. Stroger Jr. Hospital of Cook County and serves as Chief Operating Officer of the Ruth M. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases. His clinical and research interests focus on healthcare-acquired infections (particularly the epidemiology and control of antimicrobial resistance and infections in intensive care units), rapid HIV testing, and healthcare costs and outcomes for healthcare-acquired infections and for patients with HIV/AIDS. Dr. Weinstein is a past president of the Society for Healthcare Epidemiology of America (SHEA) and past chair of CDC’s Healthcare Infection Control Practices Advisory Committee (HICPAC). He is also the C. Anderson Hedberg, MD, Professor of Medicine at Rush University Medical College, in Chicago.